Mereo BioPharma Group

NASDAQ: MREO · Real-Time Price · USD
1.74
0.03 (1.75%)
At close: Aug 15, 2025, 3:59 PM
1.74
0.00%
After-hours: Aug 15, 2025, 06:25 PM EDT

Mereo BioPharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-11.97 -10.34 -2.65 14.68
PEG Ratio
0.12 0.28 0.01 -0.14
PS Ratio
n/a 30.47 60.04 5.12
PB Ratio
8.49 6.03 1.46 2.12
P/FCF Ratio
-15.44 -14.14 -2.33 -32.35
P/OCF Ratio
-15.77 -14.42 -2.33 -35.65
OCF/S Ratio
n/a -2.11 -25.76 -0.14
Debt / Equity Ratio
0.11 0.12 0.21 0.19
Quick Ratio
5.40 6.72 2.63 8.06
Current Ratio
5.40 6.72 2.52 7.92
Asset Turnover
n/a 0.15 0.02 0.29
Interest Coverage
-34.56 -9.86 -12.96 -4.01
Return on Equity
-0.71 -0.58 -0.55 0.14
Return on Assets
-0.57 -0.44 -0.39 0.10
Return on Invested Capital
-0.69 -0.48 -0.55 -0.16
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a 0.74 0.38 0.51
Net Profit Margin
n/a -2.95 -22.69 0.35
Pretax Profit Margin
n/a -3 -23.95 0.39
Operating Profit Margin
n/a -2.84 -28.91 -0.57
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a -2.61 -27.91 -0.14